NCT00074841
Completed
Phase 2
A Phase II/III, Randomized, Comparative Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in India
ConditionsPLASMODIUM FALCIPARUM MALARIA
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- PLASMODIUM FALCIPARUM MALARIA
- Sponsor
- Pfizer
- Enrollment
- 230
- Locations
- 1
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
This primary objective of this study is to assess whether the combination of Azithromycin with chloroquine is non-inferior to the combination of sulfadoxine-pyrimethamine plus chloroquine, when used to treat uncomplicated cases of malaria due to Plasmodium falciparum in adults in India.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In AfricaMalaria, FalciparumNCT00677833Pfizer361
Terminated
Phase 2
Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium FalciparumMalaria, FalciparumNCT00082563Pfizer14
Completed
Phase 2
Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South AmericaMalaria, FalciparumNCT00084227Pfizer244
Completed
Phase 2
Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in AfricaMalaria, FalciparumNCT00082576Pfizer238
Completed
Phase 2
Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in BangladeshUncomplicated Falciparum MalariaNCT00356005Medical University of Vienna228